Renal Disease 2
1. State the major points of the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKFKDOQI) for chronic kidney disease.
2. Accurately identify, screen, evaluate, and classify patients who are at risk or have the diagnosis of CKD.
3. Reduce the risk for progression of CKD to end-stage renal disease (ESDR) by applying appropriate, proven therapeutic interventions early in the disease process.
4. Describe the management strategies for anemia, bone disease, malnutrition, and electrolyte abnormalities in the later stages of CKD.
View technical requirements (opens in a new window).
View CME credit information (opens in a new window).
View AAFP staff list (opens in a new window).
View disclosures and disclaimers (opens in a new window).
All materials herein are protected by copyright and are for the sole, personal use of the purchaser. No part of the written, oral, and broadcast production may be copied, duplicated, replicated or retransmitted without the prior permission of the applicable copyright owner.
The unauthorized reproduction or distribution of a copyrighted work is illegal. Criminal copyright infringement, including infringement without monetary gain, is investigated by the FBI and is punishable by up to five years in federal prison and a fine of $250,000.
Gary I. Levine, MD, FAAFP, Associate Professor, Department of Family Medicine, Brody School of Medicine at East Carolina University, Greenville, North Carolina
- 0.75 AAFP prescribed